Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12311010 | Formulated and/or co-formulated liposome compositions containing toll-like receptor(“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof | Dhruba Bharali, Bruce A. Hay, Tahmineh Safaie | 2025-05-27 |
| 12286403 | Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof | Dhruba Bharali, Bruce A. Hay, Tahmineh Safaie | 2025-04-29 |
| 12162958 | Fusion protein composition(s) comprising masked type i interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof | Sherie L. Morrison, Alex Vasuthasawat, Kham M. Trinh, George Ayoub | 2024-12-10 |
| 12059470 | Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof | Dhruba Bharali, Bruce A. Hay, Tahmineh Safaie | 2024-08-13 |
| 11896646 | Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof | Dhruba Bharali, Bruce A. Hay, Tahmineh Safaie | 2024-02-13 |
| 11833209 | Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof | Dhruba Bharali, Bruce A. Hay, Tahmineh Safaie | 2023-12-05 |
| 11801304 | Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof | Dhruba Bharali, Bruce A. Hay, Tahmineh Safaie | 2023-10-31 |
| 11795198 | Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof | Sherie L. Morrison, Alex Vasuthasawat, Kham M. Trinh, George Ayoub | 2023-10-24 |
| 11744874 | Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof | Dhruba Bharali, Bruce A. Hay, Tahmineh Safaie | 2023-09-05 |
| 11679141 | Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof | Dhruba Bharali, Bruce A. Hay, Tahmineh Safaie | 2023-06-20 |
| 11136353 | Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof | Sherie L. Morrison, Alex Vasuthasawat, Kham M. Trinh, George Ayoub | 2021-10-05 |
| 9120855 | Biologic compounds directed against death receptor 5 | Karen Cromie, Bruno Dombrecht, Seth Ettenberg, Joost Alexander Kolkman, Jing Li +2 more | 2015-09-01 |
| 8101727 | Compositions and methods of use for antibodies of c-Met | Josef Prassler, Catrin Berger, Bodo BROCKS | 2012-01-24 |
| 6710047 | Phthalazines with angiogenesis inhibiting activity | Guido Bold, Jorg Frei, Peter Traxler, Karl-Heinz Altmann, Helmut Mett +1 more | 2004-03-23 |
| 6514974 | Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity | Guido Bold, Jorg Frei, Peter Traxler, Karl-Heinz Altmann, Helmut Mett +1 more | 2003-02-04 |
| 6258812 | Phthalazines with angiogenesis inhibiting activity | Guido Bold, Jorg Frei, Peter Traxler, Karl-Heinz Altmann, Helmut Mett +1 more | 2001-07-10 |